Top Stories

Why Analysts Are Turning Bullish on Ethereum and These Altcoins

Ethereum (ETHUSD) sits at the center of an accelerating bullish narrative that’s now drawing in both institutional players and retail…

Read More »

Why This Small-Cap Wearable Tech Stock Is Up Over 800% in the Past Month

Shares of Zepp Health (NYSE: ZEPP) have skyrocketed more than 800% in just over a month, transforming the obscure small-cap…

Read More »

Profusa Expands into Europe and Bitcoin, Joins Wall Street’s Digital Treasury Movement

Profusa (NASDAQ: PFSA), a rising player in digital health, just made two bold moves that caught the attention of investors…

Read More »

Trump Narrows Fed Chair Shortlist to Four as Markets Watch Closely

President Donald Trump has trimmed his shortlist to replace Federal Reserve Chair Jerome Powell down to four finalists, confirming in…

Read More »

Meta, Microsoft Earnings Ignite $500B Rally in AI Stocks and ETFs

The artificial intelligence boom has once again captured Wall Street’s imagination. Meta (NASDAQ: META) and Microsoft (NASDAQ: MSFT) triggered a…

Read More »

Inside the Fed’s Bloated $2.5 Billion Renovation

The Federal Reserve’s grand headquarters in Washington, D.C., once an austere symbol of financial stability, has become the center of…

Read More »

Lake Victoria Gold Launches $7.5M Private Placements to Fund Tanzanian Projects

Lake Victoria Gold (TSXV: LVG) (OTCQB: LVGLF) (FSE: E1K) has unveiled plans for a significant financing package, announcing two private…

Read More »

Robinhood Stuns Market With Stellar Q2 Earnings

Robinhood (NASDAQ: HOOD) electrified Wall Street with its second-quarter earnings report, leaving analysts scrambling. The online trading app posted explosive revenue growth…

Read More »

Fed Holds Rates Steady Despite Mounting Trump Pressure

The Federal Open Market Committee voted 9–2 to keep the federal funds rate in a 4.25%–4.50% range, pushing back against…

Read More »

Why This French Biotech Stock Just Soared 586% in One Day

Shares of Abivax SA (NASDAQ: ABVX) went parabolic on Wednesday, skyrocketing 586% to close at $68.60 after the French biotech…

Read More »
Back to top button